The department of General Hematology at Lu Daopei hospital has 31 doctors, 101 nurses, 116 beds up to Dec.31.2018.This department mainly to carry out hematopoietic malignancies chemotherapy,induced differentation therapy, targeted therapy, small molecule drug therapy, autologous hematopoietic stem cell transplantation and clinical trial of immunotherapy (include monoclonal antibodies,Bispecific monoclonal antibody BITE,CIK,DC-CIK,NK,CTL,CAR-T), it also have special treatment experience for Non-malignant hematopathy. As one of the most active Immunotherapy centers， our general hematology department has completed more than 500 cases modified second generation CAR-T clinical trials until Dec.31, 2018, including 223 cases during 2018.
Number of Employees (Dec.31,2018)
Department of BMT beds (Dec.31,2018)
Number of CAR-T
As one of the most active Immunotherapy centers，our general hematology department has completed more than 260 cases modified second generation CAR-T clinical trials until Dec.31, 2018.
What patients are benefitting from CAR-T?
The CAR-T clinical trial in Lu Daopei Hospital is for patients with B-cell acute lymphocytic leukemia（B-ALL）, B-cell lymphoma and multiple myeloma, who developed refractory or relapsed disease from chemotherapy.
CAR-T therapy could help patient into complete remission. Our CAR-T therapy CR rate is about 90%. And bridging BMT after CAR-T for B-ALL could further increase the potential cure rate.
If you want to know more details，please click here.